Annual Accounts Receivable
$42.83 M
+$19.30 M+82.05%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual accounts receivable is $42.83 million, with the most recent change of +$19.30 million (+82.05%) on December 31, 2023.
- During the last 3 years, BPMC annual accounts receivable has risen by +$35.73 million (+503.54%).
- BPMC annual accounts receivable is now at all-time high.
Performance
BPMC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$65.81 M
-$19.24 M-22.62%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly accounts receivable is $65.81 million, with the most recent change of -$19.24 million (-22.62%) on September 30, 2024.
- Over the past year, BPMC quarterly accounts receivable has increased by +$24.95 million (+61.07%).
- BPMC quarterly accounts receivable is now -22.62% below its all-time high of $85.06 million, reached on June 30, 2024.
Performance
BPMC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BPMC Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.0% | +61.1% |
| 3 y3 years | +503.5% | +87.3% |
| 5 y5 years | +10000.0% | +87.3% |
BPMC Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.0% | -22.6% | +240.7% |
| 5 y | 5-year | at high | +6359.6% | -22.6% | +9826.7% |
| alltime | all time | at high | >+9999.0% | -22.6% | >+9999.0% |
Blueprint Medicines Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $65.81 M(-22.6%) |
| Jun 2024 | - | $85.06 M(+41.7%) |
| Mar 2024 | - | $60.05 M(+40.2%) |
| Dec 2023 | $42.83 M(+82.0%) | $42.83 M(+4.8%) |
| Sep 2023 | - | $40.86 M(+16.3%) |
| Jun 2023 | - | $35.15 M(+17.1%) |
| Mar 2023 | - | $30.01 M(+27.6%) |
| Dec 2022 | $23.52 M(-6.5%) | $23.52 M(+21.8%) |
| Sep 2022 | - | $19.32 M(-28.8%) |
| Jun 2022 | - | $27.12 M(-5.7%) |
| Mar 2022 | - | $28.76 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $25.16 M(+254.5%) | $25.16 M(+36.7%) |
| Sep 2021 | - | $18.40 M(-27.8%) |
| Jun 2021 | - | $25.47 M(-26.5%) |
| Mar 2021 | - | $34.66 M(+388.5%) |
| Dec 2020 | $7.10 M(+970.3%) | $7.10 M(-84.0%) |
| Sep 2020 | - | $44.37 M(+1203.8%) |
| Jun 2020 | - | $3.40 M(-24.5%) |
| Mar 2020 | - | $4.51 M(+580.2%) |
| Dec 2019 | $663.00 K(+935.9%) | $663.00 K(-72.5%) |
| Sep 2019 | - | $2.41 M(+221.9%) |
| Jun 2019 | - | $750.00 K(+1071.9%) |
| Dec 2018 | $64.00 K | $64.00 K |
FAQ
- What is Blueprint Medicines annual accounts receivable?
- What is the all time high annual accounts receivable for Blueprint Medicines?
- What is Blueprint Medicines annual accounts receivable year-on-year change?
- What is Blueprint Medicines quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Blueprint Medicines?
- What is Blueprint Medicines quarterly accounts receivable year-on-year change?
What is Blueprint Medicines annual accounts receivable?
The current annual accounts receivable of BPMC is $42.83 M
What is the all time high annual accounts receivable for Blueprint Medicines?
Blueprint Medicines all-time high annual accounts receivable is $42.83 M
What is Blueprint Medicines annual accounts receivable year-on-year change?
Over the past year, BPMC annual accounts receivable has changed by +$19.30 M (+82.05%)
What is Blueprint Medicines quarterly accounts receivable?
The current quarterly accounts receivable of BPMC is $65.81 M
What is the all time high quarterly accounts receivable for Blueprint Medicines?
Blueprint Medicines all-time high quarterly accounts receivable is $85.06 M
What is Blueprint Medicines quarterly accounts receivable year-on-year change?
Over the past year, BPMC quarterly accounts receivable has changed by +$24.95 M (+61.07%)